DRAFT GUIDELINE FOR PHARMACEUTICAL REPRESENTATIVES IN KENYA
- Version
- Download 18
- File Size 1.03 MB
- File Count 1
- Create Date August 13, 2026
- Last Updated August 13, 2026
DRAFT GUIDELINE FOR PHARMACEUTICAL REPRESENTATIVES IN KENYA
The Pharmacy and Poisons Board (“the Board”) is the National Medicines’ Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The Board is mandated to regulate the profession of Pharmacy, the manufacture and trade in medical products and health technologies. The overall goal is to maintain the required level of oversight while facilitating innovation and access to safe, effective, and good quality medical products and professionals that are fit to practice.
The Board is committed in its mission to ensure the promotion of medicines in Kenya is done within the legal framework and that the information shared with healthcare providers remains factual, evidence based and not misleading. To this end, the Board revised the “Guideline for Advertisement and Promotion of Health Products and Technologies” to align it with the current best practices.
Pharmaceutical representatives interact with health professionals and the supply chain in many ways. They interact with prescribers and the outlets (government and private institutions, hospitals, distributors and retailers) to provide information and persuade them to prescribe or stock and sell the products they promote. The role and impact of pharmaceutical representatives on the health system is highly dependent on the training given to them and the ways they are managed.
Attached Files
